Stevens-Johnson Syndrome

Subconjunctival Humira for Boston Keratoprosthesis

Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease

Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN

Autologous Serum Obtained by a Closed-Circuit Collection Device

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.

Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study

Drug Reactions Sampling (COLLECTIONTOXIDERMIES)

Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population

Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis

Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation

Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye